Epitomee Medical Ltd (TLV:EPIT)

Epitomee Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.57	13.65	16.57	15.63	35.95	64.31
Short-Term Investments	-	-	5.51	19.16	10.18	-
Cash & Short-Term Investments	8.57	13.65	22.08	34.79	46.13	64.31
Cash Growth	-53.10%	-38.19%	-36.53%	-24.59%	-28.27%	215.12%
Other Receivables	0.41	0.17	0.21	0.17	0.18	0.39
Receivables	0.51	0.17	0.21	0.17	0.18	0.39
Inventory	1.05	0.47	0.02	-	-	-
Prepaid Expenses	-	0.06	0.05	0.03	0.06	0.1
Other Current Assets	0.01	0.05	0.13	0.07	0.13	0.04
Total Current Assets	10.14	14.4	22.49	35.06	46.51	64.83
Property, Plant & Equipment	18.46	18.32	17.43	4.93	8.42	1.13
Other Long-Term Assets	0.42	0.39	0.29	0.27	0.28	0.06
Total Assets	29.02	33.11	40.21	40.27	55.2	66.02

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.28	0.31	1.09	0.54	0.31	1.14
Accrued Expenses	-	0.8	0.82	0.96	1.37	0.99
Current Portion of Leases	0.82	0.73	0.58	0.45	0.49	0.3
Other Current Liabilities	1.52	0.47	0	0	0	0.02
Total Current Liabilities	2.62	2.31	2.5	1.96	2.16	2.45
Long-Term Leases	5.04	4.83	3.76	3.51	3.6	0.28
Long-Term Unearned Revenue	-	-	-	-	10	10
Total Liabilities	7.66	7.15	6.26	5.47	15.76	12.73

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	90.62	0.82	0.82	0.81	0.81	0.81
Additional Paid-In Capital	4.84	94.39	93.78	93.17	92.14	90.6
Retained Earnings	-74.47	-69.63	-61.02	-59.56	-53.87	-38.48
Comprehensive Income & Other	0.38	0.38	0.38	0.38	0.38	0.38
Total Common Equity	21.36	25.96	33.95	34.8	39.45	53.3
Shareholders' Equity	21.36	25.96	33.95	34.8	39.45	53.3
Total Liabilities & Equity	29.02	33.11	40.21	40.27	55.2	66.02

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	5.86	5.57	4.35	3.96	4.08	0.58
Net Cash (Debt)	2.71	8.08	17.73	30.83	42.05	63.73
Net Cash Growth	-80.32%	-54.42%	-42.48%	-26.67%	-34.03%	366.78%
Net Cash Per Share	0.09	0.27	0.60	1.04	1.43	36.24
Filing Date Shares Outstanding	30.12	29.84	29.58	29.52	29.46	29.23
Total Common Shares Outstanding	30.12	29.84	29.58	29.52	29.46	29.23
Working Capital	7.52	12.09	19.99	33.1	44.34	62.38
Book Value Per Share	0.71	0.87	1.15	1.18	1.34	1.82
Tangible Book Value	21.36	25.96	33.95	34.8	39.45	53.3
Tangible Book Value Per Share	0.71	0.87	1.15	1.18	1.34	1.82
Machinery	-	11.71	10.95	1.06	3.89	1.23
Leasehold Improvements	-	2.84	2.73	0.18	1.18	0.16

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 22, 2026

Data Sources Report a data error